SBIR Phase I: Aerogels Derived from Genetically Engineered Microbial Cells

SBIR 第一阶段：源自基因工程微生物细胞的气凝胶

• 批准号: 2050101
• 负责人: Lina Gonzalez
• 金额: $ 25.6万
• 依托单位: SPADXTECH LLC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-01 至 2023-01-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2050101&HistoricalAwards=false
• 关键词: SBIR; Phase; Aerogels; Derived; Genetically

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is development of green insulation materials for the over $50 billion-per-year building insulation industry. These materials will (i) have high R-values, (ii) be safe to install, (iii) not require toxic chemical and fossil fuel feedstocks, (iv) reduce greenhouse gas (GHG) emissions, and (v) be produced securely in the United States. By developing new biotechnology tools to make these materials, this project will advance the fields of energy conservation and material science and grow the bio-economy. The new materials will be sustainable, biologically grown versions of the best known insulation materials called aerogels. As excellent insulators requiring little energy to produce, these biological aerogels will reduce GHG emissions. Being non-toxic, the materials will be safer to make and install. Production with locally-sourced materials will secure vulnerable supply chains revealed by the SARS-CoV-2 pandemic. These materials will help meet increasing demand for green building materials. For example, Leadership in Energy and Environmental Design (LEED) certified buildings command premium new and resale prices, with under 300 certifications in 2007 growing to over 67,000 in 2018. Using genetically engineered bacteria, this SBIR Phase I project will develop an entirely new aerogel material that is a composite of bacterial cellulose (BC) and structures forming nanoscale cavities of air. This approach will circumvent the supercritical drying needed in the production of conventional aerogels, which is an expensive and energy intensive process because it requires high temperatures and high pressures. These biological aerogels materials will have excellent insulation properties comparable to conventional aerogels, (that is, high R-values) produced at a fraction of the cost. To create biological aerogels for insulation, the project plan is to (1) optimize production of the components (BC and nanoscale cavity structures), (2) use genetic engineering tools to merge the components to create a biologically-derived aerogel, and (3) create synthetic gene networks to endow the biological aerogel with hydrophobicity and fire-retardant properties needed for a building insulation material. The project will employ heterologous expression of genes in a tractable organism and systematic tuning of those genes to achieve its ambitious goals.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这个小型企业创新研究（SBIR）第一阶段项目的更广泛的影响/商业潜力是为每年超过500亿美元的建筑保温行业开发绿色保温材料。这些材料将（i）具有高R值，（ii）安装安全，（iii）不需要有毒化学品和化石燃料原料，（iv）减少温室气体（GHG）排放，以及（v）在美国安全生产。 通过开发新的生物技术工具来制造这些材料，该项目将推进节能和材料科学领域，并发展生物经济。新材料将是可持续的，生物生长版本的最知名的绝缘材料称为气凝胶。 由于生产所需能源很少，这些生物气凝胶将减少温室气体排放。由于无毒，材料的制造和安装将更加安全。使用当地来源的材料生产将确保SARS-CoV-2大流行所揭示的脆弱供应链。这些材料将有助于满足对绿色建筑材料日益增长的需求。例如，能源与环境设计领导力（LEED）认证的建筑物拥有优质的新价格和转售价格，2007年不到300个认证，2018年增长到67，000多个。利用基因工程细菌，SBIR第一阶段项目将开发一种全新的气凝胶材料，该材料是细菌纤维素（BC）和形成纳米级空气腔的结构的复合材料。这种方法将避免常规气凝胶生产中所需的超临界干燥，这是一种昂贵且能源密集的方法，因为它需要高温和高压。这些生物气凝胶材料将具有与传统气凝胶相当的优异绝缘性能（即，高R值），其生产成本仅为传统气凝胶的一小部分。为了创造用于绝缘的生物气凝胶，该项目计划是（1）优化组件（BC和纳米级空腔结构）的生产，（2）使用基因工程工具合并组件以创建生物衍生的气凝胶，以及（3）创建合成基因网络以赋予生物气凝胶建筑绝缘材料所需的疏水性和阻燃性。该项目将采用基因在易处理的有机体中的异源表达，并对这些基因进行系统调整，以实现其雄心勃勃的目标。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。